BPC-157 10MG
$34.00
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide corresponding to a partial sequence of a protein identified in gastric juice.
Published preclinical work characterizes it as a modulator of the VEGF and nitric oxide pathways and of focal adhesion kinase signaling, with more than 30 years of in vitro and animal-model literature across tendon, muscle, bone, nerve, and gastrointestinal tissue models. It is unusually stable in acidic conditions, which is why it is one of the few peptides studied by oral administration in animal models.
Researchers study BPC-157 in:
- Angiogenesis and VEGF pathway assays
- Nitric oxide signaling studies
- FAK-paxillin pathway research
- Fibroblast migration models
- Peptide stability research
For research use only. Not for human or veterinary use.
MECHANISM
How Does It Work?
BPC-157 accelerates repair through multiple interconnected pathways that support tissue rebuilding and recovery.
| New Blood Vessel Formation | Tendon & Muscle Repair |
|---|---|
| BPC-157 stimulates the formation of new blood vessels at injury sites, improving delivery of oxygen, nutrients, and repair cells where healing is needed most. | Research models consistently show accelerated recovery in torn tendons, strained muscles, and damaged ligaments compared to control groups. |
| Gut Lining Protection & Repair | Inflammation Control |
|---|---|
| Research shows BPC-157 protects and repairs the stomach and intestinal lining, making it relevant in gut health and intestinal repair research models. | BPC-157 appears to shift immune cells from an inflammatory state to a repair-focused state, reducing tissue damage and supporting recovery. |
| Nerve Repair & Neuroprotection | Growth Factor Upregulation |
|---|---|
| Studies suggest BPC-157 may support nerve regeneration and protect against neurological damage in brain, spinal cord, and peripheral nerve research models. | BPC-157 upregulates growth factors that signal the body to rebuild damaged tissue, amplifying natural repair mechanisms. |
One notable feature of BPC-157 is its chemical stability. It resists enzymatic degradation even in harsh acidic conditions, which is why it is studied in both injectable and oral research protocols.
PHYSICAL PROPERTIES
| Property | Details |
|---|---|
| Full Name | Body Protection Compound-157 |
| Amino Acids | 15 amino acids (pentadecapeptide) |
| Molecular Weight | 1,419.5 g/mol |
| Form | White lyophilized powder |
| Solubility | Water-soluble. Stable in acidic conditions. |
| Purity | 98%+ (HPLC verified) |
| Administration | Subcutaneous injection or oral administration |
| Storage | Refrigerated 36–46°F (2–8°C). Protect from light. Avoid freeze-thaw cycles. |
| Stability | 24 months lyophilized. Use within 30 days once reconstituted. |
POTENTIAL SIDE EFFECTS IN RESEARCH
BPC-157 has one of the strongest safety profiles among research peptides, with no established lethal dose (LD50) identified in toxicology studies. Reported side effects are generally mild and uncommon.
| Injection Site Irritation | Mild Nausea |
|---|---|
| Mild redness or swelling at the injection site. Common with peptide administration and usually resolves quickly. | Occasionally reported, particularly at higher concentrations. Mild and temporary. More common in oral administration protocols. |
| Dizziness or Lightheadedness | Mild Headache |
|---|---|
| Rarely observed. More common when combined with growth hormone peptides in research protocols. Usually short-lived. | Occasionally reported at elevated doses and generally resolves without intervention. |
| Digestive Changes | Fatigue |
|---|---|
| Minor changes in digestion or bowel habits have been observed in some oral administration studies. Typically temporary. | Mild fatigue has been reported in a small number of subjects early in research protocols and is generally short-lived. |
BPC-157 has no established lethal dose in animal toxicology studies, which researchers consider an unusually strong safety signal for a research compound. No serious adverse effects have been documented at standard research concentrations.
DISCLAIMER
This product is exclusively for laboratory research. Not approved for human or veterinary use.
All products sold by Ikon Peptides are intended exclusively for in-vitro laboratory research. Not approved for human consumption or veterinary use. These statements have not been evaluated by the FDA.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
